Skip to main content
Erschienen in: Abdominal Radiology 2/2015

01.02.2015

CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma

verfasst von: Sung Yoon Park, Byung Kwan Park, Jung Jae Park, Chan Kyo Kim

Erschienen in: Abdominal Radiology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To retrospectively compare computed tomography (CT) sensitivities of large (≥3 cm) adenoma and cortical carcinoma.

Methods

Between January 2004 and November 2012, 43 non-oncologic patients with 43 adrenal masses [31 large adenomas, and 12 carcinomas] underwent unenhanced CT, early contrast-enhanced CT, and delayed contrast-enhanced CT scans prior to adrenalectomy. Three types of region-of-interest (ROI) were used on early contrast-enhanced CT images:aROI (large ROI) covering more than half of a mass and two small ROIs fitted to the highest (high ROI) or lowest (low ROI) attenuation area. These ROIs were also placed in the same area on the other CT images. Adenoma was diagnosed if a mass measured ≤10 HU on unenhanced CT image, or if it had ≥60% absolute percentage washout (APW)or ≥40% relative percentage washout (RPW).Carcinoma was diagnosed if a mass had <60% APW and <40% RPW. CT sensitivities for large adenoma and carcinoma were compared.

Results

CT sensitivities for large adenoma vs. carcinoma were 64.5% (20/31) vs. 100% (12/12) using a large ROI, 100% (31/31) vs. 50.0% (6/12) using a high ROI, and 51.6% (16/31) vs. 100% (12/12) using a low ROIs, respectively.

Conclusions

CT sensitivities for large adenoma and cortical carcinoma are influenced by the size or location of an ROI.A large ROI helps to minimize loss of CT sensitivity for large adenoma and to detect carcinoma.
Literatur
1.
Zurück zum Zitat Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415PubMedCrossRef Caoili EM, Korobkin M, Francis IR, Cohan RH, Dunnick NR (2000) Delayed enhanced CT of lipid-poor adrenal adenomas. AJR Am J Roentgenol 175:1411–1415PubMedCrossRef
2.
Zurück zum Zitat Caoili EM, Korobkin M, Francis IR, et al. (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222:629–633PubMedCrossRef Caoili EM, Korobkin M, Francis IR, et al. (2002) Adrenal masses: characterization with combined unenhanced and delayed enhanced CT. Radiology 222:629–633PubMedCrossRef
3.
Zurück zum Zitat Korobkin M, Brodeur FJ, Francis IR, et al. (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747–752PubMedCrossRef Korobkin M, Brodeur FJ, Francis IR, et al. (1998) CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol 170:747–752PubMedCrossRef
4.
Zurück zum Zitat Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798–802PubMedCrossRef Pena CS, Boland GW, Hahn PF, Lee MJ, Mueller PR (2000) Characterization of indeterminate (lipid-poor) adrenal masses: use of washout characteristics at contrast-enhanced CT. Radiology 217:798–802PubMedCrossRef
5.
Zurück zum Zitat Park BK, Kim CK, Kim B, Lee JH (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765PubMedCrossRef Park BK, Kim CK, Kim B, Lee JH (2007) Comparison of delayed enhanced CT and chemical shift MR for evaluating hyperattenuating incidental adrenal masses. Radiology 243:760–765PubMedCrossRef
6.
Zurück zum Zitat Paulsen SD, Nghiem HV, Korobkin M, Caoili EM, Higgins EJ (2004) Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies. AJR Am J Roentgenol 182:1033–1037PubMedCrossRef Paulsen SD, Nghiem HV, Korobkin M, Caoili EM, Higgins EJ (2004) Changing role of imaging-guided percutaneous biopsy of adrenal masses: evaluation of 50 adrenal biopsies. AJR Am J Roentgenol 182:1033–1037PubMedCrossRef
7.
Zurück zum Zitat Szolar DH, Korobkin M, Reittner P, et al. (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234:479–485PubMedCrossRef Szolar DH, Korobkin M, Reittner P, et al. (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234:479–485PubMedCrossRef
8.
Zurück zum Zitat Park BK, Kim B, Ko K, Jeong SY, Kwon GY (2006) Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol 16:642–647PubMedCrossRef Park BK, Kim B, Ko K, Jeong SY, Kwon GY (2006) Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol 16:642–647PubMedCrossRef
9.
Zurück zum Zitat Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29:1333–1351PubMedCrossRef Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29:1333–1351PubMedCrossRef
10.
Zurück zum Zitat Newhouse JH, Heffess CS, Wagner BJ, et al. (1999) Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology 210:385–391PubMedCrossRef Newhouse JH, Heffess CS, Wagner BJ, et al. (1999) Large degenerated adrenal adenomas: radiologic-pathologic correlation. Radiology 210:385–391PubMedCrossRef
11.
Zurück zum Zitat Aubert S, Wacrenier A, Leroy X, et al. (2002) Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26:1612–1619PubMedCrossRef Aubert S, Wacrenier A, Leroy X, et al. (2002) Weiss system revisited: a clinicopathologic and immunohistochemical study of 49 adrenocortical tumors. Am J Surg Pathol 26:1612–1619PubMedCrossRef
12.
Zurück zum Zitat Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757–768PubMedCrossRef Lau SK, Weiss LM (2009) The Weiss system for evaluating adrenocortical neoplasms: 25 years later. Hum Pathol 40:757–768PubMedCrossRef
13.
Zurück zum Zitat NIH (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 19:1–25 NIH (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“incidentaloma”). NIH Consens State Sci Statements 19:1–25
14.
15.
Zurück zum Zitat Angeli A, Osella G, Ali A, Terzolo M (1997) Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 47:279–283PubMedCrossRef Angeli A, Osella G, Ali A, Terzolo M (1997) Adrenal incidentaloma: an overview of clinical and epidemiological data from the National Italian Study Group. Horm Res 47:279–283PubMedCrossRef
16.
Zurück zum Zitat Terzolo M, Ali A, Osella G, Mazza E (1997) Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 132:914–919PubMedCrossRef Terzolo M, Ali A, Osella G, Mazza E (1997) Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici. Arch Surg 132:914–919PubMedCrossRef
17.
Zurück zum Zitat Mantero F, Arnaldi G (2000) Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 29:107–125, ix Mantero F, Arnaldi G (2000) Management approaches to adrenal incidentalomas. A view from Ancona, Italy. Endocrinol Metab Clin North Am 29:107–125, ix
18.
Zurück zum Zitat Mantero F, Terzolo M, Arnaldi G, et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644PubMed Mantero F, Terzolo M, Arnaldi G, et al. (2000) A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab 85:637–644PubMed
19.
Zurück zum Zitat Ctvrtlik F, Herman M, Student V, Ticha V, Minarik J (2009) Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 69:243–252PubMedCrossRef Ctvrtlik F, Herman M, Student V, Ticha V, Minarik J (2009) Differential diagnosis of incidentally detected adrenal masses revealed on routine abdominal CT. Eur J Radiol 69:243–252PubMedCrossRef
20.
Zurück zum Zitat Boland GW, Lee MJ, Gazelle GS, et al. (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201–204PubMedCrossRef Boland GW, Lee MJ, Gazelle GS, et al. (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201–204PubMedCrossRef
21.
Zurück zum Zitat Choi YA, Kim CK, Park BK, Kim B (2013) Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology 266:514–520PubMedCrossRef Choi YA, Kim CK, Park BK, Kim B (2013) Evaluation of adrenal metastases from renal cell carcinoma and hepatocellular carcinoma: use of delayed contrast-enhanced CT. Radiology 266:514–520PubMedCrossRef
22.
Zurück zum Zitat Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical shift MRI and washout CT. AJR Am J Roentgenol 202(5):1043–1050PubMedCrossRef Seo JM, Park BK, Park SY, Kim CK (2014) Characterization of lipid-poor adrenal adenoma: chemical shift MRI and washout CT. AJR Am J Roentgenol 202(5):1043–1050PubMedCrossRef
23.
Zurück zum Zitat Kumar R, Xiu Y, Yu JQ, et al. (2004) 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45:2058–2062PubMed Kumar R, Xiu Y, Yu JQ, et al. (2004) 18F-FDG PET in evaluation of adrenal lesions in patients with lung cancer. J Nucl Med 45:2058–2062PubMed
24.
Zurück zum Zitat Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 192:956–962PubMedCrossRef Boland GW, Blake MA, Holalkere NS, Hahn PF (2009) PET/CT for the characterization of adrenal masses in patients with cancer: qualitative versus quantitative accuracy in 150 consecutive patients. AJR Am J Roentgenol 192:956–962PubMedCrossRef
25.
Zurück zum Zitat Kim YK, Park BK, Kim CK, Park SY (2013) Adenoma characterization: adrenal protocol with dual-energy CT. Radiology 267:155–163PubMedCrossRef Kim YK, Park BK, Kim CK, Park SY (2013) Adenoma characterization: adrenal protocol with dual-energy CT. Radiology 267:155–163PubMedCrossRef
26.
Zurück zum Zitat Korobkin M, Brodeur FJ, Francis IR, et al. (1996) Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 200:737–742PubMedCrossRef Korobkin M, Brodeur FJ, Francis IR, et al. (1996) Delayed enhanced CT for differentiation of benign from malignant adrenal masses. Radiology 200:737–742PubMedCrossRef
Metadaten
Titel
CT sensitivities for large (≥3 cm) adrenal adenoma and cortical carcinoma
verfasst von
Sung Yoon Park
Byung Kwan Park
Jung Jae Park
Chan Kyo Kim
Publikationsdatum
01.02.2015
Verlag
Springer US
Erschienen in
Abdominal Radiology / Ausgabe 2/2015
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0202-1

Weitere Artikel der Ausgabe 2/2015

Abdominal Radiology 2/2015 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.